Correlation Between GCM Grosvenor and DiaMedica Therapeutics

Can any of the company-specific risk be diversified away by investing in both GCM Grosvenor and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GCM Grosvenor and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GCM Grosvenor and DiaMedica Therapeutics, you can compare the effects of market volatilities on GCM Grosvenor and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GCM Grosvenor with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GCM Grosvenor and DiaMedica Therapeutics.

Diversification Opportunities for GCM Grosvenor and DiaMedica Therapeutics

0.05

Correlation Coefficient

GCM Grosvenor  DiaMedica Therapeutics

Significant diversification

The 3 months correlation between GCM and DiaMedica is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding GCM Grosvenor and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and GCM Grosvenor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GCM Grosvenor are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of GCM Grosvenor i.e., GCM Grosvenor and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between GCM Grosvenor and DiaMedica Therapeutics

Given the investment horizon of 90 days GCM Grosvenor is expected to generate 0.31 times more return on investment than DiaMedica Therapeutics. However, GCM Grosvenor is 3.27 times less risky than DiaMedica Therapeutics. It trades about 0.21 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  845.00  in GCM Grosvenor on March 4, 2024 and sell it today you would earn a total of  160.00  from holding GCM Grosvenor or generate 18.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

GCM Grosvenor  vs.  DiaMedica Therapeutics

GCM Grosvenor

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in GCM Grosvenor are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent primary indicators, GCM Grosvenor reported solid returns over the last few months and may actually be approaching a breakup point.

DiaMedica Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DiaMedica Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, DiaMedica Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with GCM Grosvenor and DiaMedica Therapeutics

The main advantage of trading using opposite GCM Grosvenor and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GCM Grosvenor position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.

The idea behind GCM Grosvenor and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.